Inactive
Notice ID:CAE2005189
The Defense Health Agency (DHA) is issuing this sources sought synopsis as a means of conducting market research to identify parties having an interest in and the resources to meet requirements for EB...
The Defense Health Agency (DHA) is issuing this sources sought synopsis as a means of conducting market research to identify parties having an interest in and the resources to meet requirements for EBMS-D. Enterprise Blood Management System – Donor (EBMS-D) and its associated components (i.e. Analytics), an FDA-regulated Class II medical device. This includes the configuration, implementation, and maintenance activities required to deploy new versions of WellSky™ Donor (future releases and/or upgrades of application software throughout the life of the sustainment contract) to include interfaces with other clinical systems (i.e. CHCS and other specified government interfaces). This also includes the maintenance and sustainment of the HBSS on the EBMS production, training, and testing servers and the management of HBSS on all EBMS servers at Wilford Hall Ambulatory Surgical Center (WHASC) data center San Antonio, TX, all COOP EBMS servers.